MARC details
000 -LEADER |
fixed length control field |
02917nam a22003497a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
210628s20212021 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1932-2968 |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1177/19322968211016513 [doi] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
34008442 |
245 ## - TITLE STATEMENT |
Title |
Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles. |
251 ## - Source |
Source |
Journal of Diabetes Science & Technology. :19322968211016513, 2021 May 19 |
252 ## - Abbreviated Source |
Abbreviated source |
J Diabetes Sci Technol. :19322968211016513, 2021 May 19 |
253 ## - Journal Name |
Journal name |
Journal of diabetes science and technology |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2021 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2021 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Publication date |
2021 May 19 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Publication status |
aheadofprint |
266 ## - Date added to catalog |
Date added to catalog |
2021-06-28 |
520 ## - SUMMARY, ETC. |
Abstract |
CONCLUSIONS: CGM confirmed that the patch or pen can be used to safely initiate and optimize basal-bolus therapy using a simple insulin adjustment algorithm with SMBG. Preference data suggest that use of the patch vs pen may enhance treatment adherence. |
520 ## - SUMMARY, ETC. |
Abstract |
METHODS: Study participants (patch, n = 49; pen, n = 48) wore a CGM device in masked setting during the baseline period and prior to week 24. Glycemic control was assessed using international consensus guidelines for percentage of Time In Range (%TIR: >70% at 70-180 mg/dL), Time Below Range (%TBR: <4% at <70 mg/dL; <1% at <54 mg/dL), and Time Above Range (%TAR: <25% at >180 mg/dL; <5% at >250 mg/dL). |
520 ## - SUMMARY, ETC. |
Abstract |
OBJECTIVE: CeQur Simplicity TM (CeQur, Marlborough, MA) is a 3-day insulin delivery patch designed to meet mealtime insulin requirements. A recently reported 48-week, randomized, multicenter, interventional trial compared efficacy, safety and self-reported outcomes in 278 adults with type 2 diabetes (T2D) on basal insulin therapy who initiated and managed mealtime insulin therapy with a patch pump versus insulin pen. We assessed changes in key glycemic metrics among a subset of patients who wore a continuous glucose monitoring (CGM) device. |
520 ## - SUMMARY, ETC. |
Abstract |
RESULTS: Both the patch and pen groups achieved recommended targets in %TIR (74.1% +/- 18.7%, 75.2 +/- 16.1%, respectively) and marked reductions in %TAR >180 mg/dL (21.1% +/- 19.9%, 19.7% +/- 17.5%, respectively) but with increased %TBR <70 mg/dL (4.7% +/- 5.2%, 5.1 +/- 5.8, respectively), all P < .0001. No significant between-group differences in glycemic improvements or adverse events were observed. |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
IN PROCESS -- NOT YET INDEXED |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Health Research Institute |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Journal Article |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Aroda, Vanita R |
790 ## - Authors |
All authors |
Aroda VR, Bergenstal RM, Brazg RL, Dreon DM, Frias JP, Johnson ML, Kruger DF, Levy BL, Molitch ME, Mullen DM, Peyrot M, Richter S, Rosenstock J, Serusclat P, Vance C, Weinstock RS |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.1177/19322968211016513">https://dx.doi.org/10.1177/19322968211016513</a> |
Public note |
https://dx.doi.org/10.1177/19322968211016513 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |